Compare ALEMBIC LTD with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs STERLING BIOTECH - Comparison Results

ALEMBIC LTD     Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD STERLING BIOTECH ALEMBIC LTD/
STERLING BIOTECH
 
P/E (TTM) x 66.7 -0.4 - View Chart
P/BV x 2.4 0.0 16,627.1% View Chart
Dividend Yield % 0.4 0.0 -  

Financials

 ALEMBIC LTD   STERLING BIOTECH
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
STERLING BIOTECH
Dec-13
ALEMBIC LTD/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs7211 685.7%   
Low Rs343 997.1%   
Sales per share (Unadj.) Rs4.726.8 17.5%  
Earnings per share (Unadj.) Rs6.1-15.0 -40.8%  
Cash flow per share (Unadj.) Rs6.2-5.5 -114.3%  
Dividends per share (Unadj.) Rs0.200-  
Dividend yield (eoy) %0.40-  
Book value per share (Unadj.) Rs40.754.9 74.1%  
Shares outstanding (eoy) m267.03267.87 99.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.30.3 4,344.8%   
Avg P/E ratio x8.7-0.5 -1,867.0%  
P/CF ratio (eoy) x8.5-1.3 -666.4%  
Price / Book Value ratio x1.30.1 1,028.3%  
Dividend payout %3.30-   
Avg Mkt Cap Rs m14,1391,862 759.5%   
No. of employees `000NA1.4 0.0%   
Total wages/salary Rs m207547 37.9%   
Avg. sales/employee Rs ThNM5,303.3-  
Avg. wages/employee Rs ThNM403.8-  
Avg. net profit/employee Rs ThNM-2,959.0-  
INCOME DATA
Net Sales Rs m1,2557,181 17.5%  
Other income Rs m37043 869.0%   
Total revenues Rs m1,6257,223 22.5%   
Gross profit Rs m111947 11.7%  
Depreciation Rs m382,543 1.5%   
Interest Rs m24,377 0.0%   
Profit before tax Rs m442-5,931 -7.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m24-1,924 -1.2%   
Profit after tax Rs m1,630-4,007 -40.7%  
Gross profit margin %8.913.2 67.1%  
Effective tax rate %5.432.4 16.7%   
Net profit margin %129.8-55.8 -232.7%  
BALANCE SHEET DATA
Current assets Rs m1,86714,335 13.0%   
Current liabilities Rs m59149,809 1.2%   
Net working cap to sales %101.6-494.0 -20.6%  
Current ratio x3.20.3 1,097.4%  
Inventory Days Days94403 23.4%  
Debtors Days Days74171 43.1%  
Net fixed assets Rs m1,79155,432 3.2%   
Share capital Rs m534268 199.4%   
"Free" reserves Rs m10,32413,935 74.1%   
Net worth Rs m10,85814,701 73.9%   
Long term debt Rs m419,478 0.4%   
Total assets Rs m11,59173,988 15.7%  
Interest coverage x260.9-0.4 -73,496.1%   
Debt to equity ratio x00.6 0.6%  
Sales to assets ratio x0.10.1 111.6%   
Return on assets %14.10.5 2,810.3%  
Return on equity %15.0-27.3 -55.1%  
Return on capital %15.2-6.4 -236.4%  
Exports to sales %1.525.9 6.0%   
Imports to sales %21.00.2 12,348.4%   
Exports (fob) Rs m191,860 1.0%   
Imports (cif) Rs m26312 2,158.5%   
Fx inflow Rs m191,860 1.0%   
Fx outflow Rs m26425 1,059.9%   
Net fx Rs m-2441,835 -13.3%   
CASH FLOW
From Operations Rs m2361,719 13.7%  
From Investments Rs m-224-3,148 7.1%  
From Financial Activity Rs m-271,426 -1.9%  
Net Cashflow Rs m-15-3 435.3%  

Share Holding

Indian Promoters % 64.0 33.9 188.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 0.0 -  
FIIs % 9.7 9.9 98.0%  
ADR/GDR % 0.0 16.9 -  
Free float % 26.1 39.3 66.4%  
Shareholders   54,701 21,482 254.6%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   DIVIS LABORATORIES  WOCKHARDT  AUROBINDO PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  

Compare ALEMBIC LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 262 Points Lower; Oil & Gas and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended lower. At the closing bell, the BSE Sensex stood lower by 262 points (down 0.7%).

Related Views on News

ALEMBIC LTD Announces Quarterly Results (1QFY20); Net Profit Down 70.9% (Quarterly Result Update)

Aug 27, 2019 | Updated on Aug 27, 2019

For the quarter ended June 2019, ALEMBIC LTD has posted a net profit of Rs 20 m (down 70.9% YoY). Sales on the other hand came in at Rs 260 m (down 41.5% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (4QFY19); Net Profit Down 14.6% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, ALEMBIC LTD has posted a net profit of Rs 40 m (down 14.6% YoY). Sales on the other hand came in at Rs 253 m (down 23.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

ALEMBIC LTD Announces Quarterly Results (1QFY19); Net Profit Up 106.9% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, ALEMBIC LTD has posted a net profit of Rs 69 m (up 106.9% YoY). Sales on the other hand came in at Rs 445 m (up 50.4% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Don't Buy Lakshmi Vilas Bank...Buy this Private Sector Bank with 74% Upside(The 5 Minute Wrapup)

Sep 4, 2019

Lakshmi Vilas Bank is in a vicious cycle. The stock is already down 57% in 2019. Despite this, the retail investors increased their holding.

Insider Buying Alert: Promoters Increase Stake in 8 High-Quality Smallcaps(Profit Hunter)

Sep 3, 2019

Insiders have increased their stakes in eight Hidden Treasure recommendations. Should you follow them?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Sep 16, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS